Oncological outcomes in patients with residual triple-negative breast cancer after preoperative chemotherapy
In patients with residual TNBC, higher ypT and ypN stages were associated with poorer outcomes after NAC. RNI did not appear to improve DFS. More intensive treatments incorporating systemic therapy and RT should be considered for these patients.
Authors
- Nalee Kim (ORCID: https://orcid.org/0000-0003-4742-2772)
- Tae Gyu Kim (ORCID: https://orcid.org/0000-0002-8830-2542)
- Jonghan Yu
- Byung Joo Chae (ORCID: https://orcid.org/0000-0003-1564-0978)
- Jai-Min Ryu
- Hyunki Park (ORCID: https://orcid.org/0000-0001-6970-6536)
- Sei Kyung Lee
- Young‐Hyuck Im (ORCID: https://orcid.org/0000-0001-6459-8118)
- Haeyoung Kim (ORCID: https://orcid.org/0000-0003-1808-7573)
- Ji‐Yeon Kim (ORCID: https://orcid.org/0000-0002-6612-1732)
- Won Kyung Cho (ORCID: https://orcid.org/0000-0002-4736-8270)
- Won Park (ORCID: https://orcid.org/0000-0003-4686-2071)
- Yeon Hee Park (ORCID: https://orcid.org/0000-0003-4156-9212)
- Jeong Eon Lee (ORCID: https://orcid.org/0000-0003-0037-2456)
- Seok Won Kim (ORCID: https://orcid.org/0000-0002-1910-0242)
- Seok Jin Nam
- Jin Seok Ahn
Institutions
- Samsung (South Korea) (KR)
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Radiation Oncology Journal
- Published
- 2024-09-19
- DOI
- https://doi.org/10.3857/roj.2024.00087
- Citations
- 2
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Samsung